BioForce Nanosciences Inc, the developer of biomolecular nanoarray analysis systems, has announced the issuance of their Nanoarray patent. The patent entitled, "Method and Apparatus for Solid State Molecular Analysis", includes claims encompassing unprecedented nanoscale arrays useful in identifying target materials or for characterizing molecular interaction events.

President and Chief Executive Officer Gary Alianell, states that, "This patent is an important foundation for advancing BioForce's technological development and commercialization. It enhances the NanoPro System and allows the Company to continue to lead the industry with protected, proprietary products. It also will add significant shareholder value to the company."

The patent details methods for the creation and analysis of novel miniature deposition domains placed on a substrate to form a molecular nanoscale array. The molecular array may be scanned using Atomic Force Microscopy (AFM) or other detection methods to analyze molecular recognition events and the effect of introduced agents on defined molecular interactions. This approach can be carried out in a high throughput format, allowing rapid screening of thousands of molecular species in a solid-state array.

Inventor and company founder Eric Henderson, states that, "This patent is one of the keystones in our core technology and puts us in a uniquely advantageous position with regard to competition in the emerging miniaturized biodiagnostics industry. It has far reaching ramifications because it strongly bolsters our immediate business goals and lays the groundwork for our more future-looking ambitions in the area of bionanotechnology."

According to Henderson, the method is truly a novel and superior means of biomolecular analysis. One of the great advantages of BioForce Nanosciences' proprietary method is that it does not require labeling of the deposition material or the target sample, and may also be used to deposit large size molecules without harming them. This is a revolutionary concept and procedure for biomolecular analysis, giving way to new opportunities that will rapidly advance biological research, as well as other industrial areas.